Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Coskun Dogan"'
Autor:
Coskun Dogan, Ali Fidan, Elif Torun Parmaksız, Sevda Şener Cömert, Banu Salepçi, Benan Çağlayan
Publikováno v:
Annals of Thoracic Medicine, Vol 13, Iss 3, Pp 182-189 (2018)
PURPOSE: The purpose of this study is to investigate the effect of homogeneous/heterogeneous (necrotic) involvement and maximum standardized uptake value (SUVmax) value of the lesion on positron emission tomography-computed tomography (PET-CT) of pat
Externí odkaz:
https://doaj.org/article/8ce7e7f6d8f04d5ca3216ba40b40ff70
Autor:
Elif Çiğdem Altunok, Elif Torun Parmaksiz, Ali Fidan, Sevda Ozdogan, Coskun Dogan, Seda Beyhan Sagmen, Nesrin Kiral, Banu Salepçi, Sevda Şener Cömert, Tuba Naziroğlu
Publikováno v:
Turk Thorac J
OBJECTIVE: This study aimed to compare the success rate of 3 different drug prescription policies: Free drugs with online system prescription, free drugs with doctor’s prescription, and drugs paid for by patients with doctor’s prescription. MATER
Autor:
Coşkun Doğan, Samet Samancı
Publikováno v:
İstanbul Medical Journal, Vol 25, Iss 3, Pp 199-206 (2024)
Introduction: This study investigated the clinical and radiological characteristics and demographics of patients who developed pulmonary embolism (PE) after Coronavirus disease-2019 (COVID-19) vaccination. Methods: The cases of PE were analyzed retr
Externí odkaz:
https://doaj.org/article/91ae301a4280471aace4924d0b184714
Autor:
Ali Fidan, Nesrin Kiral, Banu Salepçi, Seda Beyhan Sagmen, Elif Torun Parmaksiz, Coskun Dogan
Publikováno v:
Genel Tip Dergisi. 29:113-118
Autor:
Coskun Dogan, Elif Torun Parmaksiz, Ali Fidan, Sevda Şener Cömert, Nesrin Kiral, Seda Beyhan Sagmen
Publikováno v:
Medical Laboratory Technology Journal, Vol 5, Iss 1, Pp 32-40 (2019)
Numerous studies determined that the neutrophil/lymphocyte (NLR) and platelet/lymphocyte ratios (PLR) had prognostic value in several cancer types. This study aimed to evaluate the relationship between NLR and PLR values with the survival time of lun
Autor:
Ali Fidan, Aysun Küçüköz Uzun, Seda Beyhan Sagmen, Çağla Yılmaz Haksal, Coskun Dogan, Guven Yilmaz, Sevda Sener Comert, Elif Torun Parmaksiz, Nesrin Kiral, Esra Turan Erkek
Publikováno v:
Acta Haematologica. 142:171-175
Aim: Bleomycin is an antitumor antibiotic used successfully to treat a variety of malignancies, predominantly germ cell tumors and Hodgkin’s lymphoma (HL). The major limitation of bleomycin therapy is the potential for life-threatening interstitial
Autor:
Seda Beyhan Sagmen, Ali Fidan, Elif Torun Parmaksiz, Coskun Dogan, Nesrin Kiral, Sevda Şener Cömert, Banu Salepçi, Benan Caglayan
Publikováno v:
Archivos de Bronconeumología. 54:619-624
To evaluate the role of ultrasonography (USG) in the diagnosis of bleomycin-induced pulmonary toxicity (BT).The study included patients with suspected BT during treatment with bleomycin due to various oncologic diseases between June 2015 and May 2017
Autor:
Gizem Turkes, Elif Torun Parmaksiz, Sevda Şener Cömert, Gulten Aktin Gungor, Nesrin Kiral, Coskun Dogan
Publikováno v:
Clinical respiratory physiology, exercise and functional imaging.
Autor:
Ali Fidan, Nesrin Kiral, Sevda Şener Cömert, Elif Torun Parmaksiz, Coskun Dogan, Nagehan Ozdemir Barisik, Şule Gül, Seda Beyhan Sagmen
Publikováno v:
Lung cancer.
Asin many tumors, the relationship betweenKi-67 proliferation index and treatment response in lung cancer is emphasized. In this study, we aimed to investigate the relationship between Ki-67proliferation index (Ki-67PI) and the therapeutic effects of
Autor:
Berrin Eraslan, Nesrin Kiral, Sevda Şener Cömert, Coskun Dogan, Benan Caglayan, Elif Torun Parmaksiz, Ali Fidan
Publikováno v:
Journal of İzmir Chest Hospital.